December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Omnicell, Inc. - Common Stock (NQ:OMCL)

34.60 +1.00 (+2.98%)
Delayed Quote Updated: 3:59 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Omnicell, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
Omnicell to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026
From Omnicell, Inc.
Via Business Wire
News headline image
3 Healthcare Stocks We Think Twice About
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory de... 
Via StockStory
News headline image
A Look Back at Healthcare Technology for Providers Stocks’ Q1 Earnings: Astrana Health (NASDAQ:ASTH) Vs The Rest Of The Pack
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers in... 
Via StockStory
News headline image
Healthcare Technology for Providers Stocks Q1 Earnings: Omnicell (NASDAQ:OMCL) Best of the Bunch
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers in... 
Via StockStory
Omnicell Inc (NASDAQ:OMCL) Surges 12% Pre-Market After Q1 Earnings Beat and Raised Full-Year Guidance ↗
Via Chartmill
Topics Earnings
News headline image
Spotting Winners: Hims & Hers Health (NYSE:HIMS) And Healthcare Technology Stocks In Q1
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the healthcare technology stocks, including Hims & Hers Health (NYSE:HIMS) and its peer... 
Via StockStory
News headline image
3 Reasons to Avoid OMCL and 1 Stock to Buy Instead
Omnicell’s 23% return over the past six months has outpaced the S&P 500 by 13%, and its stock price has climbed to $43.73 per share. This was partly due to i... 
Via StockStory
Topics Stocks
News headline image
3 Stocks Under $50 with Warning Signs
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha... 
Via StockStory
News headline image
3 Cash-Producing Stocks We Keep Off Our Radar
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Not... 
Via StockStory
News headline image
The 5 Most Interesting Analyst Questions From Omnicell’s Q1 Earnings Call
Omnicell’s first quarter was marked by strong execution and operational improvements, leading to results that exceeded Wall Street’s expectations. Management... 
Via StockStory
Topics Earnings
News headline image
Omnicell to Present at the BofA Securities 2026 Healthcare Conference
From Omnicell, Inc.
Via Business Wire
News headline image
1 Small-Cap Stock to Keep an Eye On and 2 We Ignore
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th... 
Via StockStory
News headline image
Investment Advisor Sells $6.6 Million Worth of Medical Solutions Stock, According to Recent SEC Filing ↗
Omnicell provides automation and software solutions to streamline medication management for healthcare systems and pharmacies. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Omnicell Welcomes Hospital Pharmacy Leader Rick Couldry as Senior Vice President, Chief Pharmacy and Clinical Officer
From Omnicell, Inc.
Via Business Wire
News headline image
OMCL Q1 Deep Dive: Platform Expansion and Cost Controls Drive Margin Turnaround
Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 14.9% year on year to $30... 
Via StockStory
Topics World Trade
News headline image
Why Omnicell Stock Trounced the Market on Tuesday ↗
The healthcare tech company posted strong quarterly results. 
Via The Motley Fool
News headline image
Omnicell (OMCL) Q1 2025 Earnings Transcript ↗
Omnicell (OMCL) Q1 2025 Earnings Transcript 
Via The Motley Fool
Topics Economy World Trade
News headline image
Omnicell OMCL Q2 2025 Earnings Transcript ↗
Omnicell OMCL Q2 2025 Earnings Transcript 
Via The Motley Fool
Topics World Trade
News headline image
Omnicell (OMCL) Q1 2026 Earnings Transcript ↗
Omnicell (OMCL) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics World Trade
Gapping stocks in Tuesday's session ↗
Via Chartmill
Top movers in Tuesday's pre-market session ↗
Via Chartmill
News headline image
Omnicell’s (NASDAQ:OMCL) Q1 CY2026: Beats On Revenue
Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 14.9% year on year to $3... 
Via StockStory
News headline image
Omnicell Announces First Quarter 2026 Financial Results
From Omnicell, Inc.
Via Business Wire
News headline image
Omnicell (OMCL) Q1 Earnings Report Preview: What To Look For
Healthcare tech company Omnicell (NASDAQ:OMCL) will be announcing earnings results this Tuesday before market hours. Here’s what to look for. Omnicell met an... 
Via StockStory
News headline image
Spotting Winners: Omnicell (NASDAQ:OMCL) And Healthcare Technology for Providers Stocks In Q4
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Omnicell (NASDAQ:OMCL) and it... 
Via StockStory
News headline image
Omnicell to Release First Quarter 2026 Financial Results on April 28, 2026
From Omnicell, Inc.
Via Business Wire
News headline image
1 of Wall Street’s Favorite Stock with Impressive Fundamentals and 2 We Find Risky
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f... 
Via StockStory
Topics Firearms
AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards
From AINewsWire
Via GlobeNewswire
News headline image
Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in... 
Via StockStory
Topics Artificial Intelligence Government Stocks
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.